Clinical characteristics of patients with multiple sclerosis defined in Cuba;Caracterizacion clinica de pacientes con esclerosis multiple definida en Cuba

Revista de Neurologia

Volumn 26, Issue 153, 1998, Pages 723-728

  Cabrera Gomez J A ^a  

^a Gustavo Aldereguia Hospital   (Cuba)

Author keywords

Clinical characteristics; Comparative study; Epidemiology; Multiple sclerosis; Multiple sclerosis defined; Transversal study

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CUBA; DEMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SCORING SYSTEM; SENSORY DYSFUNCTION; AGE DISTRIBUTION; CEREBELLUM; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; EVOKED RESPONSE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOLOGY; PYRAMIDAL TRACT; SEX RATIO; SPINAL CORD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; CEREBELLUM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CUBA; DISEASE PROGRESSION; EVOKED POTENTIALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PYRAMIDAL TRACTS; QUALITY OF LIFE; SEX DISTRIBUTION; SPINAL CORD;

EID: 0032293561     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.26153.981001     Document Type: Article

References (26)

1. Matthews WB, Compston A, Allen IV, Martyn CN, eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Linvingstone; 1991.
2. Rodríguez M, Siva A, Ward J, et al. Impairment, disability and handicap in multiple sclerosis. Neurology 1994; 44: 28-33.
3. Kurland LT. The evolution of multiple sclerosis epidemiology. Ann Neurol 1994; 36 (Suppl): S2-5.
4. Cabrera JA, Manero R. Algunas consideraciones sobre esclerosis múltiple en Latinoamérica. Rev Cub Med 1975; 14: 487-504.
5. Corona T, Rodríguez JL, Otero E, Stopp L. MS in Mexico. Update 1996; 10: 23-4.
6. Tilbery CP, Felipe E, Baldauf CM, Pérez MF. Multiple sclerosis: Clinical analysis and development of 214 cases. Arq Neuropsiquiatr 1995; 53: 203-7.
7. Estrada R. Casos presentados y discutidos en las sesiones de neuropatología. Rev Cub Cir 1965; 4: 201-24.
8. Poser CM, Paty DW, Scheimberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
9. Sipe JR, Knobler RL, Panitch HL. Scripps neurological rating scale Whorsheet. Neurology 1984; 36: 1370.
10. Kurtzke JF. Expanded disability status scale. Mayo Clin Proc 1989; 64: 583.
11. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis. Neurology 1995; 45: 251-5.
12. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analysis in neurological disorders. I. Establishment of reference values. Scand J Clin Invest 1977; 37: 385-90.
13. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis. Neurology 1996; 46: 907-11.
14. Aronson KJ, Goldenberg E, Cleghorn G. Social-demographic characteristics and health status of persons with multiple sclerosis and their care givers. MS Management 1996; 3: 1-15.
15. Weinshenker BG. The natural history of multiple sclerosis. In Antel JP, et al, eds. Neurologic Clinics. Philadelphia: Saunders WB; 1995. p. 119-47.
16. Poser CM. The epidemiology of multiple sclerosis: A ueneral overview. Ann Neurol 1994; 36 (Suppl): S180-93.
17. Poser CM. The epidemiology of multiple sclerosis in Africa and Asia. In Chopra JS, et al, eds. Advances in Neurolosy. Elsevier Science Publish; 1993. p. 309-19.
18. Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 1996; 46: 1107-11.
19. Weinshenker BG, Sibley WA. Natural history and treatment of multiple sclerosis. Curr Opin Neurol 1992; 5: 203-11.
20. Pnitch HS. Interferons in multiple sclerosis. Drug 1992; 44: 946-62.
21. Rodriguez M, Silva A, Cross S, et al. Optic neuritis: A population based study in Olsmted County, Minnesota. Neuroloey 1994; 44: A374.
22. Abramsky O. Pregnancy and multiple sclerosis. Ann Neurol 1994; 36 (Suppl): S38-41.
23. Poser CM. Multiple sclerosis: Diagnosis and treatment. Med Principles Pract 1992; 93: 1-16.
24. Kurtzke JF. Clinical definition for multiple sclerosis treatment trials. Ann Neurol 1994; 36 (Suppl): S73-9.
25. Olsson T. Cerebrospinal fluid. Ann Neurol 1994; 36 (Suppl): S100-2.
26. Miller DH. The role of MRI in the diagnosis and treatment of multiple sclerosis. MS Management 1995; 2: 36-42.